These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 13998323)

  • 1. [Nuclear individuality of cancer cells].
    WAINRACH S
    Rev Clin Esp; 1963 Jan; 88():97-108. PubMed ID: 13998323
    [No Abstract]   [Full Text] [Related]  

  • 2. Chromatin organization and nuclear microenvironments in cancer cells.
    He S; Dunn KL; Espino PS; Drobic B; Li L; Yu J; Sun JM; Chen HY; Pritchard S; Davie JR
    J Cell Biochem; 2008 Aug; 104(6):2004-15. PubMed ID: 17668423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear structure in cancer cells.
    Zink D; Fischer AH; Nickerson JA
    Nat Rev Cancer; 2004 Sep; 4(9):677-87. PubMed ID: 15343274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of thromboxane synthase induces lung cancer cell death via increasing the nuclear p27.
    Leung KC; Hsin MK; Chan JS; Yip JH; Li M; Leung BC; Mok TS; Warner TD; Underwood MJ; Chen GG
    Exp Cell Res; 2009 Oct; 315(17):2974-81. PubMed ID: 19576211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer cells increase androgen sensitivity by increase in nuclear androgen receptor and androgen receptor coactivators; a possible mechanism of hormone-resistance of prostate cancer cells.
    Fujimoto N; Miyamoto H; Mizokami A; Harada S; Nomura M; Ueta Y; Sasaguri T; Matsumoto T
    Cancer Invest; 2007 Feb; 25(1):32-7. PubMed ID: 17364555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p300 modulates nuclear morphology in prostate cancer.
    Debes JD; Sebo TJ; Heemers HV; Kipp BR; Haugen DL; Lohse CM; Tindall DJ
    Cancer Res; 2005 Feb; 65(3):708-12. PubMed ID: 15705864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The increase of mitochondrial DNA content in endometrial adenocarcinoma cells: a quantitative study using laser-captured microdissected tissues.
    Wang Y; Liu VW; Xue WC; Tsang PC; Cheung AN; Ngan HY
    Gynecol Oncol; 2005 Jul; 98(1):104-10. PubMed ID: 15921730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The betaII isotype of tubulin is present in the cell nuclei of a variety of cancers.
    Yeh IT; Ludueña RF
    Cell Motil Cytoskeleton; 2004 Feb; 57(2):96-106. PubMed ID: 14691949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nuclear membrane in multidrug resistance: microinjection of epirubicin into bladder cancer cell lines.
    Featherstone JM; Speers AG; Lwaleed BA; Hayes MC; Cooper AJ; Birch BR
    BJU Int; 2005 May; 95(7):1091-8. PubMed ID: 15839939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The psychological and emotional fallout of cancer and its treatment.
    Meyerowitz BE; Kurita K; D'Orazio LM
    Cancer J; 2008; 14(6):410-3. PubMed ID: 19060606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing adaptation during treatment and the role of individual differences.
    Carver CS
    Cancer; 2005 Dec; 104(11 Suppl):2602-7. PubMed ID: 16247785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of nuclear translocation of nuclear factor-{kappa}B contributes to 3,3'-diindolylmethane-induced apoptosis in breast cancer cells.
    Rahman KW; Sarkar FH
    Cancer Res; 2005 Jan; 65(1):364-71. PubMed ID: 15665315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nuclear matrix protein, NRP/B, enhances Nrf2-mediated oxidative stress responses in breast cancer cells.
    Seng S; Avraham HK; Jiang S; Yang S; Sekine M; Kimelman N; Li H; Avraham S
    Cancer Res; 2007 Sep; 67(18):8596-604. PubMed ID: 17875699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cancer nuclear microenvironment: interface between light microscopic cytology and molecular phenotype.
    True LD; Jordan CD
    J Cell Biochem; 2008 Aug; 104(6):1994-2003. PubMed ID: 18041766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor promotes epidermal growth factor receptor nuclear accumulation by a pathway dependent on cytoskeleton integrity in human breast cancer cells.
    Cortes-Reynosa P; Robledo T; Salazar EP
    Arch Med Res; 2009 Jul; 40(5):331-8. PubMed ID: 19766894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-time subcellular imaging in live animals: new visible targets for cancer drug discovery.
    Hoffman RM
    IDrugs; 2006 Sep; 9(9):632-5. PubMed ID: 16952071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomics and pancreatic cancer treatment. Optimizing current therapy and individualizing future therapy.
    Kang SP; Saif MW
    JOP; 2008 May; 9(3):251-66. PubMed ID: 18469437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The nuclear receptors SF1 and LRH1 are expressed in endometrial cancer cells and regulate steroidogenic gene transcription by cooperating with AP-1 factors.
    Dubé C; Bergeron F; Vaillant MJ; Robert NM; Brousseau C; Tremblay JJ
    Cancer Lett; 2009 Mar; 275(1):127-38. PubMed ID: 19022561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signal transducers and activators of transcription 3 activation is involved in nuclear accumulation of beta-catenin in colorectal cancer.
    Kawada M; Seno H; Uenoyama Y; Sawabu T; Kanda N; Fukui H; Shimahara Y; Chiba T
    Cancer Res; 2006 Mar; 66(6):2913-7. PubMed ID: 16540637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of IkappaB kinase epsilon expression by the androgen receptor and the nuclear factor-kappaB transcription factor in prostate cancer.
    Péant B; Diallo JS; Lessard L; Delvoye N; Le Page C; Saad F; Mes-Masson AM
    Mol Cancer Res; 2007 Jan; 5(1):87-94. PubMed ID: 17259348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.